Literature DB >> 31632660

Altered Microbiota in Cirrhosis and Its Relationship to the Development of Infection.

Jasmohan S Bajaj1.   

Abstract

Entities:  

Year:  2019        PMID： 31632660      PMCID： PMC6784803          DOI： 10.1002/cld.827

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  15 in total

1.  Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality.

Authors:  Yanfei Chen; Jing Guo; Guirong Qian; Daiqiong Fang; Ding Shi; Lihua Guo; Lanjuan Li
Journal:  J Gastroenterol Hepatol       Date:  2015-09       Impact factor: 4.029

2.  Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

Authors:  Jasmohan S Bajaj; I Jane Cox; Naga S Betrapally; Douglas M Heuman; Mitchell L Schubert; Maiyuran Ratneswaran; Phillip B Hylemon; Melanie B White; Kalyani Daita; Nicole A Noble; Masoumeh Sikaroodi; Roger Williams; Mary M E Crossey; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-25       Impact factor: 4.052

3.  Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Jody C Olson; Ram M Subramanian; Geri Brown; Nicole A Noble; Leroy R Thacker; Patrick S Kamath
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

Review 4.  Altered Microbiome in Patients With Cirrhosis and Complications.

Authors:  Chathur Acharya; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-09       Impact factor: 11.382

5.  Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.

Authors:  Javier Fernández; Juan Acevedo; Reiner Wiest; Thierry Gustot; Alex Amoros; Carme Deulofeu; Enric Reverter; Javier Martínez; Faouzi Saliba; Rajiv Jalan; Tania Welzel; Marco Pavesi; María Hernández-Tejero; Pere Ginès; Vicente Arroyo
Journal:  Gut       Date:  2017-08-28       Impact factor: 23.059

6.  Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort.

Authors:  Jasmohan S Bajaj; Rajender K Reddy; Puneeta Tandon; Florence Wong; Patrick S Kamath; Scott W Biggins; Guadalupe Garcia-Tsao; Michael Fallon; Benedict Maliakkal; Jennifer Lai; Hugo E Vargas; Ram M Subramanian; Paul Thuluvath; Leroy R Thacker; Jacqueline G OʼLeary
Journal:  Am J Gastroenterol       Date:  2017-12-19       Impact factor: 10.864

7.  Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.

Authors:  Jasmohan S Bajaj; Chathur Acharya; Andrew Fagan; Melanie B White; Edith Gavis; Douglas M Heuman; Phillip B Hylemon; Michael Fuchs; Puneet Puri; Mitchell L Schubert; Arun J Sanyal; Richard K Sterling; Todd R Stravitz; Mohammad S Siddiqui; Velimir Luketic; Hannah Lee; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Gastroenterol       Date:  2018-06-06       Impact factor: 10.864

8.  Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort.

Authors:  Jasmohan S Bajaj; Ramazan Idilman; Leila Mabudian; Matthew Hood; Andrew Fagan; Dilara Turan; Melanie B White; Fatih Karakaya; Jessica Wang; Rengül Atalay; Phillip B Hylemon; Edith A Gavis; Robert Brown; Leroy R Thacker; Chathur Acharya; Douglas M Heuman; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Hepatology       Date:  2018-05-10       Impact factor: 17.425

9.  Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.

Authors:  Jasmohan S Bajaj; Hugo E Vargas; K Rajender Reddy; Jennifer C Lai; Jacqueline G O'Leary; Puneeta Tandon; Florence Wong; Robert Mitrani; Melanie B White; Megan Kelly; Andrew Fagan; Rohan Patil; Shaimaa Sait; Masoumeh Sikaroodi; Leroy R Thacker; Patrick M Gillevet
Journal:  Clin Gastroenterol Hepatol       Date:  2018-07-20       Impact factor: 11.382

Review 10.  Bacterial infections, sepsis, and multiorgan failure in cirrhosis.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Semin Liver Dis       Date:  2008-02       Impact factor: 6.115
View more
  8 in total

1.  Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosis.

Authors:  T Oikonomou; E Cholongitas; G Gioula; F Minti; A Melidou; E Protonotariou; E Akriviadis; I Goulis
Journal:  Hippokratia       Date:  2020 Oct-Dec       Impact factor: 0.471

2.  Gut-lung axis and dysbiosis in COVID-19.

Authors:  Busra Aktas; Belma Aslim
Journal:  Turk J Biol       Date:  2020-06-21

3.  Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice.

Authors:  Jeffrey B Warner; Ida S Larsen; Josiah E Hardesty; Ying L Song; Dennis R Warner; Craig J McClain; Rui Sun; Zhongbin Deng; Benjamin A H Jensen; Irina A Kirpich
Journal:  Front Physiol       Date:  2022-01-27       Impact factor: 4.755

Review 4.  Hepatogenous diabetes: Knowledge, evidence, and skepticism.

Authors:  Ramesh Kumar; Diego García-Compeán; Tanmoy Maji
Journal:  World J Hepatol       Date:  2022-07-27

Review 5.  The central and biodynamic role of gut microbiota in critically ill patients.

Authors:  Hannah Wozniak; Tal Sarah Beckmann; Lorin Fröhlich; Tania Soccorsi; Christophe Le Terrier; Aude de Watteville; Jacques Schrenzel; Claudia-Paula Heidegger
Journal:  Crit Care       Date:  2022-08-18       Impact factor: 19.334

Review 6.  COVID-19 and liver disease: mechanistic and clinical perspectives.

Authors:  Thomas Marjot; Gwilym J Webb; Alfred S Barritt; Andrew M Moon; Zania Stamataki; Vincent W Wong; Eleanor Barnes
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-10       Impact factor: 73.082

Review 7.  Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs.

Authors:  Shukai Zhan; Na Li; Caiguang Liu; Ren Mao; Dongxuan Wu; Tong Li; Minhu Chen; Xiaojun Zhuang; Zhirong Zeng
Journal:  Front Microbiol       Date:  2021-07-16       Impact factor: 5.640

8.  The Lipopolysaccharide-Sensing Caspase(s)-4/11 Are Activated in Cirrhosis and Are Causally Associated With Progression to Multi-Organ Injury.

Authors:  Ugo Soffientini; Nigel Beaton; Sukriti Baweja; Emmanuel Weiss; Chhagan Bihari; Abeba Habtesion; Vishal Patel; Valerie Paradis; Archana Sharma; Tu Vinh Luong; Andrew Hall; Aida Nadar; Shiv Sarin; Shilpa Chokshi; Roger Williams; Benedicte Py; Richard Moreau; Rajiv Jalan; Gautam Mehta
Journal:  Front Cell Dev Biol       Date:  2021-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.